BRAINSTORM CELL THERAPEUTICS INC. Stock Issued During Period, Shares, Restricted Stock Award, Forfeited
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Stock Issued During Period, Shares, Restricted Stock Award, Forfeited of 2.81 thousand shares for the 1-month period ending 2018-03-26, per its 10-Q filed 2018-10-29.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited · last filed 2018-10-29
- 2018-03-26: Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 1 month 2.81K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 1 month |
|---|---|
| 2018-03-26 | 2.81K shares 10-Q · filed 2018-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |